--- Query Results --- | |||
| Organization: | Alberta Precision Laboratories | ||
| Message Alert: | PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing. | ||
| Test Name/Synonym: | Patient RHD Genotyping (Rh Antigen, Variant D, RHGENO) | ||
| Clinical Indications: | This test is used to:
| ||
| Ordering Alert: | Note to ordering physician: This test will be reviewed for approval by Laboratory Medical or Scientific staff. | ||
| LABID (Connect Care): | LAB4323 | ||
| Test Code: | CALGARY ZONE: GENO CENTRAL , NORTH , SOUTH ZONE: LAB ORDERABLE ONLY | ||
| Specimen Type: | Blood | ||
| Specimen Source: | Venous | ||
| Primary Container: | EDTA Lavender | ||
| Minimum Collection Volume: | 4 mL *additional volume may be required if patient is leukopenic | ||
| Method: | Polymerase Chain Reaction (PCR) | ||
| Method and Interpretation of Results: | Patents whose genotype is RhD negative are eligible for RhIG and should receive RhD negative red blood cells. Patients whose genotype is RhD positive are not eligible for RhIG and should receive RhD positive red blood cells. | ||
| Testing Area: | Transfusion Medicine | ||
| Performing Site: | Test is referred to Canadian Blood Services | ||
| Last Updated On: | Tuesday, December 8, 2020 | ||
